The cell-mediated immune reaction in the cutaneous lesion of Chromoblastomycosis and their correlation with different clinical forms of the disease

被引:48
作者
Solange Corrêa Garcia Pires d'Ávila
Carla Pagliari
Maria Irma Seixas Duarte
机构
[1] Univ. of S. Paulo School of Medicine, Department of Pathology, São Paulo
[2] CEP. 01246-903, São Paulo, SP, Av. Dr. Arnaldo
关键词
Chromoblastomycosis; Granuloma; Immunity; Immunohistochemistry; Skin;
D O I
10.1023/A:1022948329193
中图分类号
学科分类号
摘要
Chromoblastomycosis is a fungal infection caused by dematiaceous fungi inducing skin lesions of difficult treatment and of frequent recurrence. The objective of the present investigation was to characterize cell-mediated tissue reactions in the skin in cases of Chromoblastomycosis using histopathology and immunocytochemistry methods and to correlate them with different clinical forms of Chromoblastomycosis. Biopsies from 19 patients were stained with HE and Giemsa, and serial sections were immunohistochemically stained using CD45RO, CD20, CD4, CD8, CD68, CD1a, CD34, IL4, IL10, TNF-α and IFN-γ antibodies. A quantitative and semiquantitative analysis of the cell subsets and cytokines in the inflammatory infiltrates was performed by counting ten high-power fields (400x). The cutaneous lesion presented as verrucous plaque (n = 15) or erythematous atrophic plaque (n = 4). We observed two types of tissue reaction: A) a granulomatous reaction with a suppurative granuloma with several fungi cells in the cutaneous lesion presenting as verrucous plaque; B) a granulomatous reaction with a tuberculoid granuloma with few fungi cells in the cutaneous lesion presenting as atrophic plaque. The data obtained suggest that patients with lesion presented as verrucous plaque have a type Th2 immunological response, while patients with lesion presented as erythematous atrophic plaque have a type Th1 response.
引用
收藏
页码:51 / 60
页数:9
相关论文
共 36 条
[1]  
Lacaz C.S., Porto C., Martins J.E.C., Fungos Actinomicetos e Algas de Interesse Médico 8ȩ Ed., 21, pp. 373-386, (1991)
[2]  
McGinnis M.R., Chromoblastomycosis and phaeohyphomycosis: New concepts, diagnosis and mycology, J Am Acad Dermatol, 8, 1, pp. 1-16, (1983)
[3]  
Dixon D.M., Shandomy H.J., Shandomy S., Dematiaceous fungal pathogens isolated from nature, Mycopathologia, 70, pp. 153-161, (1980)
[4]  
Silva A.C.C.M., Serra Neto A., Galvao C.E.S., Marques S.G., Saldanha A.C.R., Silva C.M.P., Et al., Cromoblastomicose produzida por Fonsecaea pedrosoi no Estado do Maranhão: Aspectos clínicos, epidemiológicos e evolutivos, Rev Soc Bras Med Trop, 25, 1, pp. 37-44, (1992)
[5]  
Pastrana Fundora F., Ramirez Albajes C., Naranjo Lorenzo M., Galiano Audivert O., Cromomicosis: Quince anos de incidencia, Rev Cuba Hig Epidemiol, 27, 3, pp. 285-292, (1989)
[6]  
Minotto R., Bernardi C.D., Mallmann L.F., Edelweiss M.I., Scroferneker M.L., Chromoblastomycosis: A review of 100 cases in the state of Rio Grande do Sul, Brasil, J Am Acad Dermatol, 44, 4, pp. 585-592, (2001)
[7]  
Carrion A.L., Chromoblastomycosis, Ann NY Acad Sci, 50, pp. 1255-1282, (1950)
[8]  
Uribe F., Zuluaga A.I., Leon W., Restrepo A., Histopathology of chromoblastomycosis, Mycopathologia, 105, pp. 1-6, (1989)
[9]  
Weedon D., The Skin, (1992)
[10]  
Esterre P., Peyrol S., Sainte-Marie D., Ptadinaud R., Grimaud J.A., Granulomatous reaction and tissue remodelling in the cutaneous lesion of chromomycosis, Virchows Archly A Pathol Anat Histopathol, 422, pp. 285-291, (1993)